AstraZeneca will invest US$50bn in the US to expand manufacturing and research

No further details on this right now.

US$50bn is a substantial investment from the firm.

AstraZeneca plc is a British-Swedish pharmaceutical and biotechnology firm

• headquarters in Cambridge, UK

Visit investingLive.com (formerly ForexLive.com) for additional, original views.

This article was written by Eamonn Sheridan at investinglive.com.

from Investinglive RSS Breaking News Feed https://ift.tt/Vaq8WLi
via IFTTT